Straumann Holding AG

Company Profile

• Business description

  Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

• Contact

  Peter Merian-Weg 12
  Basel4002
  CHE

  T: +41 619651111

  E: investor.relations@straumann.com

  https://www.straumann-group.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Instruments & Supplies

  Fiscal Year End

  31 December 2025

  Employees

  11,815